These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1380310)

  • 1. Granulocyte colony-stimulating factors as therapeutic agents.
    Donahue RE; Clark SC
    Immunol Ser; 1992; 57():637-49. PubMed ID: 1380310
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hematopoietic growth factors in the limelight. New actors on the pharmacotherapeutic stage].
    Löwenberg B
    Ned Tijdschr Geneeskd; 1991 Mar; 135(10):407-9. PubMed ID: 1708442
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of granulocyte colony stimulating factor in patients with leukopenia due to sepsis.
    Bittner EW; Hartzog JM; Chendrasekhar A
    W V Med J; 1995; 91(6):273. PubMed ID: 7502498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use of granulocyte colony-stimulating factor in infectious diseases.
    Gaviria JM; Garrido SM; Root RK
    Curr Clin Top Infect Dis; 2001; 21():302-22. PubMed ID: 11572156
    [No Abstract]   [Full Text] [Related]  

  • 7. G-CSF and M-CSF: preclinical and clinical results.
    Herrmann F; Lindemann A; Mertelsmann R
    Immunol Ser; 1992; 57():651-60. PubMed ID: 1380311
    [No Abstract]   [Full Text] [Related]  

  • 8. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C; Coleman DL
    Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the clinical use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor to intensify cancer chemotherapy.
    Fisher DC; Peters WP
    Curr Opin Hematol; 1994 May; 1(3):221-7. PubMed ID: 9371286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colony-stimulating factor for treatment of leukopenia after kidney allografting.
    Tajima A; Aso Y; Kawabe K; Suzuki K; Ohtawara Y; Ohta N; Hata M; Nakano M; Ushiyama T; Ueda D
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1369-70. PubMed ID: 1703338
    [No Abstract]   [Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor: its potential role in infectious disease.
    Hartung T
    AIDS; 1999; 13 Suppl 2():S3-9. PubMed ID: 10596675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet support and the use of cytokines.
    Bishop JF
    Stem Cells; 1994 Jul; 12(4):370-7. PubMed ID: 7524892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose cyclophosphamide in patients with operable breast cancer: recombinant human GM-CSF ameliorates drug-induced leukopenia and thrombocytopenia.
    Bregni M; Siena S; Ravagnani F; Bonadonna G; Gianni AM
    Haematologica; 1990; 75 Suppl 1():95-8. PubMed ID: 2190885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials of granulocyte colony-stimulating factors for treatment of bone marrow depression associated with cancer chemotherapy.
    Lieschke GJ; Morstyn G
    Immunol Ser; 1992; 57():671-93. PubMed ID: 1380312
    [No Abstract]   [Full Text] [Related]  

  • 15. Hematopoietic colony-stimulating factors and dose intensity.
    Petros WP; Peters WP
    Semin Oncol; 1993 Feb; 20(1):94-9. PubMed ID: 7682727
    [No Abstract]   [Full Text] [Related]  

  • 16. Vasculitis complicating granulocyte colony stimulating factor treatment of leukopenia and infection in Felty's syndrome.
    Farhey YD; Herman JH
    J Rheumatol; 1995 Jun; 22(6):1179-82. PubMed ID: 7545756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of peripheral blood stem cells mobilized with granulocyte colony-stimulating factor with or without prior standard-dose chemotherapy in patients with malignancy.
    Kobayashi N; Kasai M; Masauzi N; Ogasawara M; Kiyama Y; Naohara T; Higa T; Hashino S; Tanaka J; Imamura M
    Jpn J Clin Oncol; 1995 Dec; 25(6):250-7. PubMed ID: 8523821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
    Page AV; Liles WC
    Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of granulocyte colony-stimulating factor with dose-intensive chemotherapy.
    Ogawa M
    Semin Oncol; 1994 Feb; 21(1 Suppl 1):7-9. PubMed ID: 7512279
    [No Abstract]   [Full Text] [Related]  

  • 20. [Granulocyte colony-stimulating factors as a support therapy in malignant diseases].
    Riikonen P; Elonen E; Teerenhovi L
    Duodecim; 2002; 118(21):2249-54. PubMed ID: 12486962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.